After preliminary court approval in June 2026, four major opioid manufacturers and pharmacy chains await final settlement authorization with $180 million at stake.
Nearly 400 local newspapers sued OpenAI and Microsoft for systematically copying articles to train AI systems without permission.
In January 2026, a court approved testimony from 10 of 11 proposed experts in what is becoming a defining trial, allowing juries to hear from specialists…
Contingency fee financing forces mass tort attorneys to front six-figure costs while cases drag for years, leaving many firms drowning in debt.
Asbestos in aging hospital buildings triggers costly, lengthy demolition delays that extend health risks and liability exposure.
As of July 2026, Camp Lejeune claimants are receiving payments, but fewer than 1% of the 407,000 filed claims have been approved.
Behind-the-scenes settlement negotiations in mass tort cases often leave individual plaintiffs with far less than their lawyers earn.
Asbestos assessment at a West Virginia cartage facility fire location raises exposure questions for workers and first responders present during the incident.
New York sues 3M, DuPont, and Chemours for concealing PFAS water pollution linked to cancer and birth defects across Long Island.
Purdue’s bankruptcy consolidated opioid litigation into a single settlement process, creating a template for mass tort resolution that other defendants have since studied and attempted to adapt.